Rabacfosadine, CAS [[859209-74-8]]

Produktübersicht

• Artikelname: Rabacfosadine, CAS [[859209-74-8]]
• Artikelnummer: BYT-ORB2281229
• Hersteller Artikelnummer: orb2281229
• Alternativnummer: BYT-ORB2281229-1, BYT-ORB2281229-10, BYT-ORB2281229-100, BYT-ORB2281229-200, BYT-ORB2281229-25, BYT-ORB2281229-5, BYT-ORB2281229-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: VDC 1101, VDC1101, VDC-1101, Rabacfosadine, GS9219, GS-9219, GS 9219, Nucleoside Antimetabolite/Analog, NucleosideAntimetabolite, Nucleoside Antimetabolite, Analog

Produktbeschreibung

Rabacfosadine (GS-9219) is a novel prodrug designed to selectively deliver the cytotoxic nucleotide analog PMEG into tumor lymphocytes. It has been investigated in preclinical in vivo models for the treatment of B-cell lymphomas and leukemias, demonstrating targeted anti-tumor activity.

Produkteigenschaften

• Molekulargewicht: 526.53
• Reinheit: 99.43% (May vary between batches)
• CAS Nummer: [859209-74-8]
• Formel: C21H35N8O6P
• Target-Kategorie: Nucleoside Antimetabolite/Analog

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.27 mM),DMSO:80 mg/mL (151.94 mM)